Veracyte, Inc. (VCYT)
- Zacks
Here's How Much a $1000 Investment in Veracyte Made 10 Years Ago Would Be Worth Today
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
- GuruFocus.com
Vanguard Group Inc's Strategic Acquisition of Veracyte Inc Shares
Overview of the Recent Transaction On September 30, 2024, Vanguard Group Inc made a significant addition to its investment portfolio by acquiring 251,533 shares of Veracyte Inc (NASDAQ:VCYT), a leader in genomic diagnostics. This transaction increased Vanguard's total holdings in the company to 7,748,514 shares, reflecting a substantial investment in the medical diagnostics sector. The shares were purchased at a price of $34.04 each, marking a strategic move by the firm to bolster its position in the healthcare industry.
- Business Wire
New Data Presented at ASTRO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American Men
SOUTH SAN FRANCISCO, Calif., October 02, 2024--New Data Presented at ASTRO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American Men.
